Literature DB >> 26588238

Surgical Techniques for Diaphragmatic Resection During Cytoreduction in Advanced or Recurrent Ovarian Carcinoma: A Systematic Review and Meta-analysis.

Giorgio Bogani1, Antonino Ditto, Fabio Martinelli, Domenica Lorusso, Valentina Chiappa, Cristina Donfrancesco, Violante Di Donato, Alice Indini, Giovanni Aletti, Francesco Raspagliesi.   

Abstract

OBJECTIVE: Optimal cytoreduction is one the main factors improving survival outcomes in patients affected by ovarian cancer (OC). It is estimated that approximately 40% of OC patients have gross disease located on the diaphragm. However, no mature data evaluating outcomes of surgical techniques for the management of diaphragmatic carcinosis exist. In the present study, we aimed to estimate surgery-related morbidity of different surgical techniques for diaphragmatic cytoreduction in advanced or recurrent OC.
METHODS: PubMed (MEDLINE), Web of Science, and Clincaltrials.gov databases were searched for records estimating outcomes of diaphragmatic peritoneal stripping (DPS) or diaphragmatic full-thickness resection (DFTR) for OC. The meta-analysis was performed using the Cochrane Review software.
RESULTS: For the final analysis, 5 articles were available, including 272 patients. Diaphragmatic peritoneal stripping and DFTR were performed in 197 patients (72%) and 75 patients (28%), respectively. Pooled analysis suggested that the estimated pleural effusion rate was 43% and 51% after DPS and DFTR, respectively. The need for pleural punctures or chest tube placement was 4% and 9% after DPS and DFTR, respectively. The rate of postoperative pneumothorax (4% vs 9%; odds ratio, 0.31; 95% confidence interval, 0.05-2.08) and subdiaphragmatic abscess (3% vs 3%; odds ratio, 0.45; 95% confidence interval, 0.09-2.31) were similar after the execution of DPS and DFTR.
CONCLUSIONS: Diaphragmatic surgery is a crucial step during cytoreduction for advanced or recurrent OC. Obviously, the choice to perform DPS or DFTR depends on the infiltration of the diaphragmatic muscle or not. Both the procedures are associated with a low pulmonary complication and chest tube placement rates.

Entities:  

Mesh:

Year:  2016        PMID: 26588238     DOI: 10.1097/IGC.0000000000000597

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

1.  Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.

Authors:  Renee A Cowan; Jill Tseng; Vijayashree Murthy; Radhika Srivastava; Kara C Long Roche; Oliver Zivanovic; Ginger J Gardner; Dennis S Chi; Bernard J Park; Yukio Sonoda
Journal:  Gynecol Oncol       Date:  2017-09-06       Impact factor: 5.482

2.  Radical en bloc peritonectomy in advanced ovarian cancer.

Authors:  Víctor Lago; Santiago Domingo; Luis Matute; Pablo Padilla-Iserte; Marta Gurrea
Journal:  Ecancermedicalscience       Date:  2018-02-08

3.  Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma.

Authors:  Shuang Ye; Tiancong He; Shanhui Liang; Xiaojun Chen; Xiaohua Wu; Huijuan Yang; Libing Xiang
Journal:  BMC Cancer       Date:  2017-05-05       Impact factor: 4.430

4.  Postoperative pulmonary complications and outcomes in cytoreductive surgery for ovarian cancer: a propensity-matched analysis.

Authors:  Mengmeng Xu; Wei Zhang; Chen Gao; Ying Zhou; Yanhu Xie
Journal:  BMC Anesthesiol       Date:  2022-04-23       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.